Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details)

v3.23.2
Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Liabilities:    
Private warrants $ 3,325 $ 1,314
Contingent consideration $ 0 $ 1,000
Derivative asset, statement of financial position Other non-current assets Other non-current assets
Fair Value, Recurring    
Assets:    
Total assets $ 282 $ 216
Liabilities:    
Private warrants 3,325 1,314
Contingent consideration 0 1,000
Total liabilities 3,325 2,314
Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility 282 216
Level 1 | Fair Value, Recurring    
Assets:    
Total assets 0 0
Liabilities:    
Private warrants 0 0
Contingent consideration 0 0
Total liabilities 0 0
Level 1 | Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility 0 0
Level 2 | Fair Value, Recurring    
Assets:    
Total assets 0 0
Liabilities:    
Private warrants 0 0
Contingent consideration 0 0
Total liabilities 0 0
Level 2 | Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility 0 0
Level 3 | Fair Value, Recurring    
Assets:    
Total assets 282 216
Liabilities:    
Private warrants 3,325 1,314
Contingent consideration 0 1,000
Total liabilities 3,325 2,314
Level 3 | Fair Value, Recurring | Committed Equity Facility    
Assets:    
Committed equity facility $ 282 $ 216